ad

Venus Remedies Q2 Results FY27: Profit Rises 27.42% YoY, Revenue Rs 218.76 Cr, PAT Rs 25.65 Cr

26 Oct 2026 • 7:17 pm

Venus Remedies Q2 Results FY27: Profit Rises 27.42% YoY, Revenue Rs 218.76 Cr, PAT Rs 25.65 Cr

Quick Answer

Venus Remedies Q2 Results FY27 were declared on 26 October 2026 on a Consolidated basis for the July to September 2026 quarter. Revenue rose to Rs 218.76 Cr from Rs 192.75 Cr, a YoY growth of 13.49%, while net profit rose 27.42% YoY to Rs 25.65 Cr from Rs 20.13 Cr. These quarterly results also show Operating Profit of Rs 42.50 Cr, up 37.27% YoY.

Venus Remedies Ltd (VENUSREM) Q2 Results FY27 announced on 26 October 2026, covering the company's financial performance for the July to September quarter. Revenue was Rs 218.76 Cr and PAT was Rs 25.65 Cr on a Consolidated basis. Readers following the Venus Remedies Q2 Results FY27 should note that the results date was 26 October 2026, and these consolidated results come from the company's filing on NSE and BSE.

This Univest analysis of Venus Remedies Q2 Results covers the financial highlights, the business factors, the outlook and the risks in order. The results analysis begins with the Financial Highlights table, which sets this quarter's consolidated revenue, Operating Profit and net profit beside the same quarter last year.

Click Here – Get Free Investment Predictions

Venus Remedies Q2 Results FY27: Financial Highlights

Metric Q2 FY27 (Sep 26) Q2 FY26 (Sep 25) YoY Change
Revenue Rs 218.76 Cr Rs 192.75 Cr +13.49% YoY
Operating Profit Rs 42.5 Cr Rs 30.96 Cr +37.27% YoY
Net Profit (PAT) Rs 25.65 Cr Rs 20.13 Cr +27.42% YoY

Source: company filing for Venus Remedies Q2 Results FY27, 26 October 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Venus Remedies Q2 Results: What Stands Out

  • Revenue: Revenue rose 13.49% YoY to Rs 218.76 Cr from Rs 192.75 Cr, which is the headline YoY growth figure for the quarter.
  • Net profit: Net profit rose 27.42% YoY to Rs 25.65 Cr from Rs 20.13 Cr, ahead of the pace of revenue growth.
  • Operating Profit: Operating Profit increased 37.27% YoY to Rs 42.50 Cr from Rs 30.96 Cr, the fastest of the three lines.
  • Margin: Net profit margin improved to 11.7% from 10.4% in the comparison quarter, based on the consolidated results.
  • Next step: Venus Remedies Q2 Results FY27 now move to the performance analysis, which reads revenue and profit together.

Venus Remedies Q2 Results FY27: Performance Analysis

The numbers show that Venus Remedies grew revenue 13.49% YoY to Rs 218.76 Cr, while net profit rose 27.42% to Rs 25.65 Cr and Operating Profit rose 37.27% to Rs 42.50 Cr. Venus Remedies Q2 Results FY27 therefore show the profit lines growing faster than revenue, which is the core of this results analysis.

Revenue moved from Rs 192.75 Cr to Rs 218.76 Cr over the year, an increase of Rs 26.01 Cr. Operating Profit added Rs 11.54 Cr and net profit added Rs 5.52 Cr over the same period. The Venus Remedies Q2 Results FY27 therefore present an upward picture across all three lines in the quarterly results.

Investors will focus on whether revenue and net profit keep rising in the next quarterly results, because Venus Remedies Q2 Results set a higher base on every line. The YoY growth is visible in the consolidated results, and the next section turns to the business factors listed for the quarter.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth of 13.5% – The business factors begin with revenue, which grew 13.5% year on year to Rs 218.76 Cr in the latest quarter. This growth underpins the Venus Remedies Q2 Results FY27 figures for the quarter.

Net Profit Growth of 27.4% – Net profit rose 27.4% year on year to Rs 25.65 Cr, and net profit margin improved to 11.7% from 10.4% in the comparison quarter, so profit grew faster than revenue in these quarterly results.

Return on Equity of 16.79% – Return on equity was 16.79% in FY26, which gives the earlier-year context for the latest quarter's profit growth and the improved net profit margin.

FY27 Outlook After Venus Remedies Q2 Results

FY27 full-year results will depend on the quarters that follow and on the disclosures the company makes through the rest of the year. This results analysis therefore treats the Q2 figures as one data point, with consolidated revenue at Rs 218.76 Cr for the quarter.

Venus Remedies Q2 Results FY27 give the base for that comparison, with net profit at Rs 25.65 Cr and Operating Profit at Rs 42.50 Cr. The Univest Screener can help track later filings, and the risk attached to the net profit line is covered next.

Key Risks to Watch After Venus Remedies Q2 Results FY27

Volatile Quarterly Net Profit

Quarterly net profit has been volatile over the last 5 quarters, so the Rs 25.65 Cr in Venus Remedies Q2 Results FY27 is one reading in a changing series, with YoY growth of 27.42% for this quarter.

Low End of Rs 20.13 Cr

The lowest quarterly net profit over the last 5 quarters was Rs 20.13 Cr, which is also the figure recorded in the same quarter last year, so the latest quarter sits above that low.

High End of Rs 47.49 Cr

The highest quarterly net profit over the last 5 quarters was Rs 47.49 Cr, so the current Rs 25.65 Cr sits below that peak and inside the range that the company has reported.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Venus Remedies Q2 Results FY27 show consolidated revenue of Rs 218.76 Cr and net profit of Rs 25.65 Cr for the July to September 2026 quarter. These quarterly results are consolidated results, with revenue growth of 13.49% beside faster growth in Operating Profit and net profit, so later filings will show whether the pattern holds. Readers can treat Venus Remedies Q2 Results as one quarter of the year and should consult a SEBI-registered advisor before acting.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions on Venus Remedies Q2 Results FY27

What are Venus Remedies Q2 Results FY27?

Ans. Venus Remedies Q2 Results FY27 are the Consolidated quarterly results for July to September 2026, showing revenue of Rs 218.76 Cr. Alongside this, net profit was Rs 25.65 Cr, as set out in the Financial Highlights section.

What is the results date for Venus Remedies Q2 Results FY27?

Ans. The results date for Venus Remedies Q2 Results FY27 is 26 October 2026, when the company declared its Consolidated quarter. This results date is also the one used in the introduction, which sets out revenue and net profit.

What revenue was reported in Venus Remedies Q2 Results FY27?

Ans. Venus Remedies Q2 Results FY27 reported revenue of Rs 218.76 Cr for July to September 2026, compared with Rs 192.75 Cr a year earlier. This means revenue rose Rs 26.01 Cr, as the Performance Analysis section shows.

What net profit was reported in Venus Remedies Q2 Results FY27?

Ans. Venus Remedies reported net profit of Rs 25.65 Cr for the quarter, compared with Rs 20.13 Cr a year earlier. This is a 27.42% YoY rise in net profit, which the Performance Analysis section reads beside revenue.

How much YoY growth did revenue show in Venus Remedies Q2 Results FY27?

Ans. Revenue showed YoY growth of 13.49% in the quarter, rising from Rs 192.75 Cr to Rs 218.76 Cr. Compared with this, net profit grew 27.42%, so profit rose faster than revenue, as the Key Business Factors section notes.

Did net profit rise or fall in Venus Remedies Q2 Results?

Ans. Net profit rose in Venus Remedies Q2 Results, increasing from Rs 20.13 Cr to Rs 25.65 Cr, a 27.42% YoY gain. Alongside this, net profit margin improved to 11.7% from 10.4%, as the Key Business Factors section explains.

What was the Operating Profit in Venus Remedies Q2 Results FY27?

Ans. Operating Profit in Venus Remedies Q2 Results FY27 was Rs 42.50 Cr, up 37.27% YoY from Rs 30.96 Cr. Alongside this, the Rs 11.54 Cr rise is the largest rupee gain among profit lines, per the Performance Analysis section.

Are Venus Remedies Q2 Results consolidated results or standalone results?

Ans. Venus Remedies Q2 Results are consolidated results, as the company reported the July to September 2026 quarter on a Consolidated basis. This means the revenue of Rs 218.76 Cr and net profit of Rs 25.65 Cr cover the consolidated entity.

What business factors shaped Venus Remedies Q2 Results FY27?

Ans. The business factors for Venus Remedies Q2 Results FY27 are 13.5% revenue growth, a 27.4% rise in net profit, an 11.7% margin and FY26 return on equity of 16.79%. These are detailed in the Key Business Factors section.

What are the key risks after Venus Remedies Q2 Results FY27?

Ans. The key risk after Venus Remedies Q2 Results FY27 is volatile quarterly net profit, which ranged from Rs 20.13 Cr to Rs 47.49 Cr over the last 5 quarters. The Key Risks section covers this range in more detail.

What is the outlook after Venus Remedies Q2 Results?

Ans. FY27 full-year results will depend on the quarters that follow, so Venus Remedies Q2 Results are one data point. Alongside this, the Outlook section keeps to revenue of Rs 218.76 Cr and net profit of Rs 25.65 Cr.

Where can I find the complete Venus Remedies Q2 Results FY27 data?

Ans. The complete Venus Remedies Q2 Results FY27 data, including revenue, Operating Profit and net profit, is in the Financial Highlights table of this article. Alongside this, the Univest Screener lists further quarterly results for listed companies.


Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down